Left bundle branch pacing in heart failure patients with left bundle branch block: A systematic review and

Yuda Cheng1, Zhanqi Wang1, Yujun Li1

  • 1Department of Cardiology, Affiliated Hospital of Hebei University, YuHua street, Baoding, Hebei, 071000, China.

Insights

Left bundle branch pacing (LBBP) shows significant efficacy and safety in heart failure patients with left bundle branch block (LBBB). This novel pacing strategy improves key cardiac metrics and clinical outcomes, offering a promising alternative to traditional CRT.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) benefits heart failure patients with left bundle branch block (LBBB).
  • A significant non-response rate exists for CRT, necessitating alternative approaches.
  • Left bundle branch pacing (LBBP) has emerged as a potentially effective CRT strategy.

Purpose of the Study:

  • To evaluate the efficacy and safety of LBBP in heart failure patients diagnosed with LBBB.
  • To compare the outcomes of LBBP with baseline and biventricular pacing (BVP).

Main Methods:

  • A systematic literature search was conducted across PubMed, Cochrane Library, Web of Science, and CNKI.
  • Data on QRS duration, NYHA class, BNP, LVEF, LVEDD, and pacing parameters were extracted.
  • Meta-analysis techniques were employed to summarize findings from 6 included studies.

Main Results:

  • LBBP demonstrated a high success rate (93.2%) and significantly shortened QRS duration.
  • Improvements were observed in echocardiographic parameters (LVEF, LVEDD) and clinical outcomes (NYHA, BNP).
  • LBBP showed superior outcomes compared to BVP in several key metrics, with a low complication rate (2.4%).

Conclusions:

  • LBBP is an effective and safe pacing strategy for heart failure patients with LBBB.
  • Further randomized controlled trials are needed to definitively establish LBBP's superiority over BVP.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
481
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
100
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
169
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
73
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
79
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K